Lacutamab (IPH4102) 是一种针对免疫受体分子KIR3DL2的人源单克隆抗体 (mAb)，通过重组技术在 CHO 细胞中产生。Lacutamab 可用于皮肤 T 细胞淋巴瘤的研究。
| 生物活性 | Lacutamab (IPH4102) is a humanized monoclonal antibody (mAb) directed against the immune receptor moleculeKIR3DL2, produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com